english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Statins in primary cardiovascular prevention. Little benefit, documented harms and many uncertainties regarding long-term use

In the July/August issue of Prescrire International: pembrolizumab (Keytruda°) in Hodgkin lymphoma with no further treatment options

Prescrire's review of drug packaging in 2017: some progress, but many risks remain

Multiple sclerosis: a drug that should never have been authorised

Drug prices, therapeutic value and access to medicines: civil society adds its voice to the debate in France, to defend the public interest

Drugs for Alzheimer's disease: finally delisted in France!

Human papillomavirus 9-valent vaccine (Gardasil 9°) and cervical cancer. A few cases of dysplasia prevented, but an increase in painful reactions

In the June issue of Prescrire International: anti-TNF alpha is linked to lymphoma; tropicamide eye drops present a risk of misuse

Antibiotics: repeated treatments before the age of two could be a factor in obesity

Independence, in the service of patients' best interests

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90